Article
Prognostic utility of BRAF mutation in papillary thyroid cancer.
Molecular and cellular endocrinology - 28 May 2010
Xing Mingzhao
Abstract excerpt
Papillary thyroid cancer (PTC) is a common endocrine malignancy that frequently harbors the oncogenic T1799A BRAF mutation. As a novel prognostic molecular marker, this mutation has received considerable attention in recent years for its potential utility in the risk stratification and management of PTC. In PTC, BRAF mutation is closely associated with extrathyroidal extension, lymph node metastasis, advanced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
